Skip to main content
. 2018 May 31;11:182. doi: 10.3389/fnmol.2018.00182

Figure 3.

Figure 3

Genetic interaction experiments show that CPT1 and CPT2 mitigate locomotor dysfunction caused by TDPWT and TDPG298S, in a variant dependent manner. (A) CPT1 knock-down by RNAi (CPT1RNAi, using y1v1; P{y[+t7.7] v[+t1.8] = TRiP.HMS00040}attP2/TM3, Sb1) mitigates TDPWT and TDPG298S larval turning times. (B) CPT2 loss of function (CPT2f02667, using w1118; PBac{w[+mC]=WH}CPT2f02667/TM6B, Tb1) mitigates TDPG298S larval turning times. TDPWT or TDPG298S were expressed in motor neurons using D42 GAL4. Genotypes as indicated. Kruskal-Wallis multiple comparisons test was used to calculate significance. *Pvalue < 0.05, **Pvalue < 0.01, ****Pvalue < 0.0001.